Loading...
XNAS
AMST
Market cap5mUSD
Oct 08, Last price  
0.89USD
1D
-2.20%
1Q
-21.93%
IPO
-98.45%
Name

Amesite Inc

Chart & performance

D1W1MN
XNAS:AMST chart
P/E
—
P/S
15.98
EPS
—
Div yield, %
—
Shrs. gr., 5y
23.56%
Rev. gr., 5y
-11.57%
Revenues
365k
+230.24%
014,92059,749674,580697,000845,009166,881110,459364,777
Net income
-3m
L-14.41%
-980,204-3,938,931-4,170,302-11,586,292-9,059,923-4,153,303-4,403,182-3,617,086-3,095,838
CFO
-2m
L-12.57%
-134,347-2,234,792-2,810,102-5,334,686-6,715,652-3,249,176-2,813,779-2,455,248-2,146,717

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation. Amesite Inc. was founded in 2017 and is headquartered in Detroit, Michigan.
IPO date
Sep 25, 2020
Employees
14
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT